JPRN-jRCT2080224871已完成3 期
A Phase III, Placebo-controlled, Randomized, Double-blind, Multicenter, Parallel-group comparative study to Evaluate the Efficacy and Safety of Patient Initiated Therapy of ASP2151 in Patients with Recurrent Genital Herpes
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 578
研究概览
简要总结
In this study, amenamevir significantly shortened the time to all lesion healing of recurrent genital herpes over placebo. Amenamevir was well tolerated and showed no clinically major safety concerns.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Recurrent Genital Herpes patients
排除标准
- •(1)Patients diagnosed with immunodeficiency or immunocompromised function (such as patients with congenital immunodeficiency, AIDS patients, patients with HIV infection)
- •(2)Patients with any disorders that should not be enrolled in the sutdy such as;
- •-severe cardiac disorders
- •-severe hepatic disorders
- •-severe pulmonary disorders
- •-severe blood disorders
- •(3)Pregnant women, women who may be pregnant, lactating women or women who wish to become pregnant or women who are unwilling to use a suitable method of contraception as directed by the principal investigator or sub-investigator.
研究者
相似试验
已完成
3 期
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in AdultsInfluenzaNCT02008344MDVI, LLC1,161
已完成
3 期
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316InfluenzaNCT02026349MDVI, LLC860
已完成
不适用
A Phase III Study of Pancreatic CancerPancreatic CancerNCT00994721National Health Research Institutes, Taiwan147
终止
3 期
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A InfectionInfluenza ANCT03376321Janssen Research & Development, LLC334
终止
3 期
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing ComplicationsInfluenza ANCT03381196Janssen Research & Development, LLC553